Similar articles

• Consistent prolonged "concordant" survival of hamster-to-rat cardiac xenografts by inhibition of anti-species antibodies with methotrexate.

  Hasan RI, Sriwatanawongsa V, Wallwork J, White DJ. Hasan RI, et al. Transplant Proc. 1993 Feb;25(1 Pt 1):421-2. Transplant Proc. 1993. PMID: 8438362 No abstract available.
• Long-term xenograft survival and suppression of xenoantibody formation in the hamster-to-rat heart transplant model using a combination therapy of leflunomide and cyclosporine.

  Lin Y, Sobis H, Vandeputte M, Waer M. Lin Y, et al. Transplant Proc. 1994 Dec;26(6):3202. Transplant Proc. 1994. PMID: 7998115 No abstract available.
• Prolonged survival of hamster to rat heart xenografts with cyclophosphamide therapy.

  Hasan RI, van den Bogaerde J, Forty J, Wright L, Wallwork J, White DJ. Hasan RI, et al. Transplant Proc. 1992 Apr;24(2):517-8. Transplant Proc. 1992. PMID: 1566412 No abstract available.
• Treatment strategies of hamster-to-rat cardiac xenotransplantation.

  Steinbrüchel DA, Nielsen B, Kemp E. Steinbrüchel DA, et al. Transplant Proc. 1994 Apr;26(2):1039-41. Transplant Proc. 1994. PMID: 8171460 Review. No abstract available.
• Pathogenesis and mechanisms of graft rejection in concordant xenotransplantation with special reference to hamster-to-rat cardiac transplantation.

  Steinbrüchel DA. Steinbrüchel DA. APMIS Suppl. 1996;58:5-45. doi: 10.1111/j.1600-0463.1996.tb05559.x. APMIS Suppl. 1996. PMID: 8608038 Review. No abstract available.